(12) United States Patent (10) Patent No.: US 8,377,639 B2 Ryder (45) Date of Patent: Feb

Total Page:16

File Type:pdf, Size:1020Kb

(12) United States Patent (10) Patent No.: US 8,377,639 B2 Ryder (45) Date of Patent: Feb US008377639B2 (12) United States Patent (10) Patent No.: US 8,377,639 B2 Ryder (45) Date of Patent: Feb. 19, 2013 (54) COMPOUNDS FOR MODULATING RNA (56) References Cited BINDING PROTEINS AND USES THEREFOR |U.S. PATENT DOCUMENTS (75) Inventor: Sean Ryder, West Boylston, MA (US) 3,953,492 A * 4/1976 Mrozik ............................. 558/6 (73) Assignee: University of Massachusetts, Boston, FOREIGN PATENT DOCUMENTS WO WO86/03941 A1 7/1986 MA (US) WO WO02/083629 A1 10/2002 WO WO2004/046095 A1 6/2004 (*) Notice: Subject to any disclaimer, the term of this WO WO2006/110762 A2 10/2006 patent is extended or adjusted under 35 OTHER PUBLICATIONS U.S.C. 154(b) by 29 days. Massacret et al., Palladium(0)-Catalyzed Asymmetric Synthesis of (21) Appl. No.: 12/823,902 1,2,3,4-Tetrahydro-2-vinylquinoxalines, Eur, J. Org. Chem. 1999, 129-134.” Seftel et al., Comparison of Piperazine and Tetramisole in Treatment (22) Filed: Jun. 25, 2010 of Ascariasis, Brit. med. J., 1968, 4, 93-95.” International Search Report and Written Opinion issued in PCT/ (65) Prior Publication Data US2010/040035 on Jun. 29, 2011. |US 2011/0065704 A1 Mar 17, 2011 Mueller, Joachim et al., “Thioureides of 2-(phenoxymethyl)benzoic acid 4-R substituted: A novel class of anti-parasitic compounds”, Parasitology International, 2009, 58(2), pp. 128-135. (Available online Dec. 25, 2008). Related U.S. Application Data (60) Provisional application No. 61/220,985, filed on Jun. * cited by examiner 26, 2009. Primary Examiner – Jim Ketter Assistant Examiner – Reza Ghafoorian (51) Int. Cl. (74) Attorney, Agent, or Firm – McCarter & English, LLP; CI2O I/68 (2006.01) Elizabeth A. Hanley, Esq.; Jill Mello A ().IN 4 I./06 (2006.01) A0IN 43/653 (2006.01) (57) ABSTRACT A6 IK 31/18 (2006.01) The invention relates to compositions and methods for inhib A6 IK 31/41.96 (2006.01) iting RNA binding proteins (e.g., MEX-3, MEX-5 and POS (52) U.S. Cl. ...... 435/6.1: 514/383: 514/604: 548/263.6; 1), as well as methods for treating and preventing disorders 548/264.8: 564/89; 56.4/92; 564/152; 564/191 associated with parasitic infections and inflammatory disor (58) Field of Classification Search ........................ None ders. See application file for complete search history. 28 Claims, No Drawings US 8,377,639 B2 1 2 COMPOUNDS FOR MODULATING RNA pounds that inhibit the RNA-binding activity of MEX-3, BINDING PROTEINS AND USES THEREFOR MEX-5 and/or POS-1, RNA binding proteins which are required for early embryogenesis in parasitic worms. The RELATED APPLICATIONS identified compounds represent a novel class of anti-parasitic agents that specifically target parasitic worm embryos. This application claims priority to U.S. Provisional Patent Application No. 61/220,985, filed Jun. 26, 2009. The entire Accordingly, in one aspect, the invention pertains, at least contents of the foregoing application are hereby incorporated in part, to method for treating or preventing a parasitic asso in their entirety. ciated state in a subject comprising administering to the sub ject an effective amount of an RNA binding modulatory com GOVERNMENT INTERESTS 10 pound (e.g., a compound of formula I, Ia, Ib, II, IIa, IIb, IIc, III, IV, V, VI, VIa, VIb, VII, VIIa, VIIb, VIIc, VIId, VIIe, VIIf This invention was made with government support under or a compound of Table 1 or 2), such that the parasitic asso grant nos. 1R21NS059380 and 3R21NS059380-01S1 ciated state is treated or prevented. In one embodiment, the awarded by the National Institutes of Health. The government 15 parasitic associated state is a parasitic infestation or re-infes has certain rights in the invention. tation. In another embodiment, the parasitic associated state SUBMISSION ON COMPACT DISC is a disease caused by a parasitic infestation. In one embodiment, the invention pertains, at least in part, This application incorporates by reference the ASCII text to a method for treating or preventing a parasitic infestation in file identified by the name SequenceListing.txt, containing 20 a subject infested with or at risk for infestation with parasites 1.49 KB of data, created on Nov. 12, 2010 and filed in com by administering to the subject a therapeutically or pesticid puter-readable format (CRF). ally effective amount of an RNA binding modulatory com pound, e.g., a compound of formula I, Ia, Ib, II, IIa, IIb, IIc, BACKGROUND OF THE INVENTION III, IV, V, VI, VIa, VIb, VII, VIIa, VIIb, VIIc, VIId, VIIe, VIIf According to the World Health Organization (WHO), more 25 or a compound of Table 1 or 2, such that the parasitic infes than one-third of the world’s population, approximately 2 tation is treated or prevented. billion people, is infested with helminths. In 1999, the WHO In another embodiment, the invention pertains, at least in estimated that schistosomiasis and soil-based helminths rep part, to a method for protection of plants from a parasitic resented more than 40% of the disease burden due to all infestation by administering to the plants a pesticidally effec tropical disease, excluding malaria. While most parasitic 30 tive amount of an RNA binding modulatory compound, e.g., infestations are preventable and treatable, the effects of an a compound of formula I, Ia, Ib, II, IIa, IIb, IIc, III, IV, V, VI, infestation can be chronic and long-term and may eventually VIa, VIb, VII, VIIa, VIIb, VIIc, VIId, VIIe, VIIf or a com cause death. For example, a person who has endured persis pound of Table 1 or 2, such that the plants are protected. tent and heavy infestations is likely to suffer from anemia, In yet another embodiment, the invention pertains, at least malnutrition and chronic irreversible diseases, such as liver 35 in part, to a method for inhibiting parasitic embryogenesis in fibrosis, cancer of the bladder and kidney failure. These para a parasite or in a subject suffering from a parasitic infection sites also affect livestock, which can facilitate infestation in by administering to the parasite or subject suffering from the humans by causing contamination via soil or food supplies. parasitic infection a therapeutically or pesticidally effective In addition to the health risk posed to humans by parasites, amount of an RNA binding modulatory compound, e.g., a plants are highly susceptible to parasitic infestations. Effects 40 compound of formula I, Ia, Ib, II, IIa, IIb, IIc, III, IV, V, VI, of nematode damage to plants include stunting, chlorosis, VIa, VIb, VII, VIIa, VIIb, VIIc, VIId, VIIe, VIIf or a com nutrient deficiencies, wilting, root abnormalities and reduced pound of Table 1 or 2, such that embryogenesis is inhibited. yield. In a further embodiment, the invention pertains, at least in While there are a number of antihelminthic treatments part, to a method for reducing parasitic burden in soil, in currently available, some scientists are concerned that the 45 plants or in an animal suffering from a parasitic infection by parasites will develop resistance to these treatments, espe administering to the soil, plants or animal atherapeutically or cially in developing countries where people are repeatedly pesticidally effective amount of an RNA binding modulatory infected with helminths and receive multiple doses of anti compound, e.g., a compound of formula I, Ia, Ib, II, IIa, IIb, helminthic drugs. In fact, resistance to antihelminthic drugs IIc, III, IV, V, VI, VIa, VIb, VII, VIIa, VIIb, VIIc, VIId, VIIe, has been observed in livestock due to frequent and repeated 50 VIIf or a compound of Table 1 or 2, such that the parasitic treatments. Moreover, rates of re-infection by helminths are burden is reduced. very high due to the number and the durability of infective In another embodiment, the invention pertains, at least in eggs on surfaces and in soil. While infection is active, some part, to a method for treating or preventing a disease caused parasitic nematode species (e.g., Ascaris lumbricoides) by a parasitic infestation in a subject by administering to the release an estimated 100,000 new embryos per adult female 55 subject a therapeutically effective amount of an RNA binding per day. Currently available anti-helminthics work by para modulatory compound, e.g., a compound of formula I, Ia, Ib, lyzing the infectious nematode through blocking ion channels II, IIa, IIb, IIc, III, IV, V, VI, VIa, VIb, VII, VIIa, VIIb, VIIc, and receptors and do not inactivate the embryos that cause VIId, VIIe, VIIf or a compound of Table 1 or 2, such that the re-infection. Therefore, it is advantageous to develop new disease is treated or prevented. therapies for the treatment and prevention of parasitic infes 60 In one embodiment, the invention pertains, at least in part, tations and, in particular, therapies that limit the possibility of to a method for treating or preventing an inflammatory disor parasitic re-infection, in both plants and animals, der in a subject by administering to the subject a therapeuti cally effective amount of an RNA binding modulatory com SUMMARY OF THE INVENTION pound, e.g., a compound of formula I, Ia, Ib, II, IIa, IIb, IIc, 65 III, IV, V, VI, VIa, VIb, VII, VIIa, VIIb, VIIc, VIId, VIIe, VIIf The present invention is based, at least in part, on the or a compound of Table 1 or 2, such that the inflammatory development and use of screening assays to identify com disorder is treated. US 8,377,639 B2 3 4 In one embodiment, the subject is a plant. In one embodi In one aspect, the present invention provides methods of ment, the subject is an animal. In one embodiment, the subject identifying a compound useful in modulating embryogenesis.
Recommended publications
  • TRBA 464 Biologische Arbeitsstoffe in Risikogruppen
    Ausgabe Juli 2013 Technische Regeln für Einstufung von Parasiten TRBA 464 Biologische Arbeitsstoffe in Risikogruppen Die Technischen Regeln für Biologische Arbeitsstoffe (TRBA) geben den Stand der Technik, Arbeitsmedizin und Arbeitshygiene sowie sonstige gesicherte wissenschaftliche Erkenntnisse für Tätigkeiten mit biologischen Arbeitsstoffen, einschließlich deren Einstufung, wieder. Sie werden vom Ausschuss für Biologische Arbeitsstoffe ermittelt bzw. angepasst und vom Bundesministerium für Arbeit und Soziales im Gemeinsamen Ministerialblatt bekannt gegeben. Die TRBA „Einstufung von Parasiten in Risikogruppen“ konkretisiert im Rahmen des Anwendungsbereichs die Anforderungen der Biostoffverordnung. Bei Einhaltung der Technischen Regeln kann der Arbeitgeber insoweit davon ausgehen, dass die entsprechenden Anforderungen der Verordnung erfüllt sind. Die Einstufungen der biologischen Arbeitsstoffe in Risikogruppen werden nach dem Stand der Wissenschaft vorgenommen; der Arbeitgeber hat die Einstufung zu beachten. Die vorliegende Technische Regel schreibt die Technische Regel „Einstufung von Parasiten in Risikogruppen“ (Stand Oktober 2002) fort und wurde unter Federführung des Fachbereichs „Rohstoffe und chemische Industrie“ in Anwendung des Kooperationsmodells (vgl. Leitlinienpapier1 zur Neuordnung des Vorschriften- und Regelwerks im Arbeitsschutz vom 31. August 2011) erarbeitet. Inhalt 1 Anwendungsbereich 2 Allgemeines 3 Liste der Einstufungen der Parasiten 3.1 Vorbemerkungen 3.2 Einstufung der Endoparasiten von Mensch und Haustieren (einschließlich
    [Show full text]
  • Molecular Detection of Human Parasitic Pathogens
    MOLECULAR DETECTION OF HUMAN PARASITIC PATHOGENS MOLECULAR DETECTION OF HUMAN PARASITIC PATHOGENS EDITED BY DONGYOU LIU Boca Raton London New York CRC Press is an imprint of the Taylor & Francis Group, an informa business CRC Press Taylor & Francis Group 6000 Broken Sound Parkway NW, Suite 300 Boca Raton, FL 33487-2742 © 2013 by Taylor & Francis Group, LLC CRC Press is an imprint of Taylor & Francis Group, an Informa business No claim to original U.S. Government works Version Date: 20120608 International Standard Book Number-13: 978-1-4398-1243-3 (eBook - PDF) This book contains information obtained from authentic and highly regarded sources. Reasonable efforts have been made to publish reliable data and information, but the author and publisher cannot assume responsibility for the validity of all materials or the consequences of their use. The authors and publishers have attempted to trace the copyright holders of all material reproduced in this publication and apologize to copyright holders if permission to publish in this form has not been obtained. If any copyright material has not been acknowledged please write and let us know so we may rectify in any future reprint. Except as permitted under U.S. Copyright Law, no part of this book may be reprinted, reproduced, transmitted, or utilized in any form by any electronic, mechanical, or other means, now known or hereafter invented, including photocopying, microfilming, and recording, or in any information storage or retrieval system, without written permission from the publishers. For permission to photocopy or use material electronically from this work, please access www.copyright.com (http://www.copyright.com/) or contact the Copyright Clearance Center, Inc.
    [Show full text]
  • Pathophysiology and Gastrointestinal Impacts of Parasitic Helminths in Human Being
    Research and Reviews on Healthcare: Open Access Journal DOI: 10.32474/RRHOAJ.2020.06.000226 ISSN: 2637-6679 Research Article Pathophysiology and Gastrointestinal Impacts of Parasitic Helminths in Human Being Firew Admasu Hailu1*, Geremew Tafesse1 and Tsion Admasu Hailu2 1Dilla University, College of Natural and Computational Sciences, Department of Biology, Dilla, Ethiopia 2Addis Ababa Medical and Business College, Addis Ababa, Ethiopia *Corresponding author: Firew Admasu Hailu, Dilla University, College of Natural and Computational Sciences, Department of Biology, Dilla, Ethiopia Received: November 05, 2020 Published: November 20, 2020 Abstract Introduction: This study mainly focus on the major pathologic manifestations of human gastrointestinal impacts of parasitic worms. Background: Helminthes and protozoan are human parasites that can infect gastrointestinal tract of humans beings and reside in intestinal wall. Protozoans are one celled microscopic, able to multiply in humans, contributes to their survival, permits serious infections, use one of the four main modes of transmission (direct, fecal-oral, vector-borne, and predator-prey) and also helminthes are necked multicellular organisms, referred as intestinal worms even though not all helminthes reside in intestines. However, in their adult form, helminthes cannot multiply in humans and able to survive in mammalian host for many years due to their ability to manipulate immune response. Objectives: The objectives of this study is to assess the main pathophysiology and gastrointestinal impacts of parasitic worms in human being. Methods: Both primary and secondary data were collected using direct observation, books and articles, and also analyzed quantitativelyResults and and conclusion: qualitatively Parasites following are standard organisms scientific living temporarily methods. in or on other organisms called host like human and other animals.
    [Show full text]
  • Co-Infection with Onchocerca Volvulus and Loa Loa Microfilariae in Central Cameroon: Are These Two Species Interacting?
    843 Co-infection with Onchocerca volvulus and Loa loa microfilariae in central Cameroon: are these two species interacting? S. D. S. PION1,2*, P. CLARKE3, J. A. N. FILIPE2,J.KAMGNO1,J.GARDON1,4, M.-G. BASA´ N˜ EZ2 and M. BOUSSINESQ1,5 1 Laboratoire mixte IRD (Institut de Recherche pour le De´veloppement) – CPC (Centre Pasteur du Cameroun) d’Epide´miologie et de Sante´ publique, Centre Pasteur du Cameroun, BP 1274, Yaounde´, Cameroun 2 Department of Infectious Disease Epidemiology, St Mary’s campus, Norfolk Place, London W2 1PG, UK 3 Infectious Disease Epidemiology Unit London School of Hygiene and Tropical Medicine Keppel Street, London WC1E 7HT, UK 4 Institut de Recherche pour le De´veloppement, UR 24 Epide´miologie et Pre´vention, CP 9214 Obrajes, La Paz, Bolivia 5 Institut de Recherche pour le De´veloppement, De´partement Socie´te´s et Sante´, 213 rue La Fayette, 75480 Paris Cedex 10, France (Received 16 August 2005; revised 3 October; revised 9 December 2005; accepted 9 December 2005; first published online 10 February 2006) SUMMARY Ivermectin treatment may induce severe adverse reactions in some individuals heavily infected with Loa loa. This hampers the implementation of mass ivermectin treatment against onchocerciasis in areas where Onchocerca volvulus and L. loa are co-endemic. In order to identify factors, including co-infections, which may explain the presence of high L. loa micro- filaraemia in some individuals, we analysed data collected in 19 villages of central Cameroon. Two standardized skin snips and 30 ml of blood were obtained from each of 3190 participants and the microfilarial (mf) loads of both O.
    [Show full text]
  • Performance of Two Serodiagnostic Tests for Loiasis in A
    Performance of two serodiagnostic tests for loiasis in a Non-Endemic area Federico Gobbi, Dora Buonfrate, Michel Boussinesq, Cédric Chesnais, Sébastien Pion, Ronaldo Silva, Lucia Moro, Paola Rodari, Francesca Tamarozzi, Marco Biamonte, et al. To cite this version: Federico Gobbi, Dora Buonfrate, Michel Boussinesq, Cédric Chesnais, Sébastien Pion, et al.. Perfor- mance of two serodiagnostic tests for loiasis in a Non-Endemic area. PLoS Neglected Tropical Dis- eases, Public Library of Science, 2020, 14 (5), pp.e0008187. 10.1371/journal.pntd.0008187. inserm- 02911633 HAL Id: inserm-02911633 https://www.hal.inserm.fr/inserm-02911633 Submitted on 4 Aug 2020 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. PLOS NEGLECTED TROPICAL DISEASES RESEARCH ARTICLE Performance of two serodiagnostic tests for loiasis in a Non-Endemic area 1 1 2 2 Federico GobbiID *, Dora Buonfrate , Michel Boussinesq , Cedric B. Chesnais , 2 1 1 1 3 Sebastien D. Pion , Ronaldo Silva , Lucia Moro , Paola RodariID , Francesca Tamarozzi , Marco Biamonte4, Zeno Bisoffi1,5 1 IRCCS Sacro
    [Show full text]
  • Descripción De Nuevas Especies Animales De La Península Ibérica E Islas Baleares (1978-1994): Tendencias Taxonómicas Y Listado Sistemático
    Graellsia, 53: 111-175 (1997) DESCRIPCIÓN DE NUEVAS ESPECIES ANIMALES DE LA PENÍNSULA IBÉRICA E ISLAS BALEARES (1978-1994): TENDENCIAS TAXONÓMICAS Y LISTADO SISTEMÁTICO M. Esteban (*) y B. Sanchiz (*) RESUMEN Durante el periodo 1978-1994 se han descrito cerca de 2.000 especies animales nue- vas para la ciencia en territorio ibérico-balear. Se presenta como apéndice un listado completo de las especies (1978-1993), ordenadas taxonómicamente, así como de sus referencias bibliográficas. Como tendencias generales en este proceso de inventario de la biodiversidad se aprecia un incremento moderado y sostenido en el número de taxones descritos, junto a una cada vez mayor contribución de los autores españoles. Es cada vez mayor el número de especies publicadas en revistas que aparecen en el Science Citation Index, así como el uso del idioma inglés. La mayoría de los phyla, clases u órdenes mues- tran gran variación en la cantidad de especies descritas cada año, dado el pequeño núme- ro absoluto de publicaciones. Los insectos son claramente el colectivo más estudiado, pero se aprecia una disminución en su importancia relativa, asociada al incremento de estudios en grupos poco conocidos como los nematodos. Palabras clave: Biodiversidad; Taxonomía; Península Ibérica; España; Portugal; Baleares. ABSTRACT Description of new animal species from the Iberian Peninsula and Balearic Islands (1978-1994): Taxonomic trends and systematic list During the period 1978-1994 about 2.000 new animal species have been described in the Iberian Peninsula and the Balearic Islands. A complete list of these new species for 1978-1993, taxonomically arranged, and their bibliographic references is given in an appendix.
    [Show full text]
  • (<I>Alces Alces</I>) of North America
    University of Tennessee, Knoxville TRACE: Tennessee Research and Creative Exchange Doctoral Dissertations Graduate School 12-2015 Epidemiology of select species of filarial nematodes in free- ranging moose (Alces alces) of North America Caroline Mae Grunenwald University of Tennessee - Knoxville, cgrunenw@vols.utk.edu Follow this and additional works at: https://trace.tennessee.edu/utk_graddiss Part of the Animal Diseases Commons, Other Microbiology Commons, and the Veterinary Microbiology and Immunobiology Commons Recommended Citation Grunenwald, Caroline Mae, "Epidemiology of select species of filarial nematodes in free-ranging moose (Alces alces) of North America. " PhD diss., University of Tennessee, 2015. https://trace.tennessee.edu/utk_graddiss/3582 This Dissertation is brought to you for free and open access by the Graduate School at TRACE: Tennessee Research and Creative Exchange. It has been accepted for inclusion in Doctoral Dissertations by an authorized administrator of TRACE: Tennessee Research and Creative Exchange. For more information, please contact trace@utk.edu. To the Graduate Council: I am submitting herewith a dissertation written by Caroline Mae Grunenwald entitled "Epidemiology of select species of filarial nematodes in free-ranging moose (Alces alces) of North America." I have examined the final electronic copy of this dissertation for form and content and recommend that it be accepted in partial fulfillment of the equirr ements for the degree of Doctor of Philosophy, with a major in Microbiology. Chunlei Su,
    [Show full text]
  • The Complete Mitochondrial Genome of Echinostoma Miyagawai
    Infection, Genetics and Evolution 75 (2019) 103961 Contents lists available at ScienceDirect Infection, Genetics and Evolution journal homepage: www.elsevier.com/locate/meegid Research paper The complete mitochondrial genome of Echinostoma miyagawai: Comparisons with closely related species and phylogenetic implications T Ye Lia, Yang-Yuan Qiua, Min-Hao Zenga, Pei-Wen Diaoa, Qiao-Cheng Changa, Yuan Gaoa, ⁎ Yan Zhanga, Chun-Ren Wanga,b, a College of Animal Science and Veterinary Medicine, Heilongjiang Bayi Agricultural University, Daqing, Heilongjiang Province 163319, PR China b College of Life Science and Biotechnology, Heilongjiang Bayi Agricultural University, Daqing, Heilongjiang Province 163319, PR China ARTICLE INFO ABSTRACT Keywords: Echinostoma miyagawai (Trematoda: Echinostomatidae) is a common parasite of poultry that also infects humans. Echinostoma miyagawai Es. miyagawai belongs to the “37 collar-spined” or “revolutum” group, which is very difficult to identify and Echinostomatidae classify based only on morphological characters. Molecular techniques can resolve this problem. The present Mitochondrial genome study, for the first time, determined, and presented the complete Es. miyagawai mitochondrial genome. A Comparative analysis comparative analysis of closely related species, and a reconstruction of Echinostomatidae phylogeny among the Phylogenetic analysis trematodes, is also presented. The Es. miyagawai mitochondrial genome is 14,416 bp in size, and contains 12 protein-coding genes (cox1–3, nad1–6, nad4L, cytb, and atp6), 22 transfer RNA genes (tRNAs), two ribosomal RNA genes (rRNAs), and one non-coding region (NCR). All Es. miyagawai genes are transcribed in the same direction, and gene arrangement in Es. miyagawai is identical to six other Echinostomatidae and Echinochasmidae species. The complete Es. miyagawai mitochondrial genome A + T content is 65.3%, and full- length, pair-wise nucleotide sequence identity between the six species within the two families range from 64.2–84.6%.
    [Show full text]
  • Comparative Genomics of the Major Parasitic Worms
    Comparative genomics of the major parasitic worms International Helminth Genomes Consortium Supplementary Information Introduction ............................................................................................................................... 4 Contributions from Consortium members ..................................................................................... 5 Methods .................................................................................................................................... 6 1 Sample collection and preparation ................................................................................................................. 6 2.1 Data production, Wellcome Trust Sanger Institute (WTSI) ........................................................................ 12 DNA template preparation and sequencing................................................................................................. 12 Genome assembly ........................................................................................................................................ 13 Assembly QC ................................................................................................................................................. 14 Gene prediction ............................................................................................................................................ 15 Contamination screening ............................................................................................................................
    [Show full text]
  • For Onchocerciasis on Parasitological Indicators of Loa Loa Infection
    pathogens Article Collateral Impact of Community-Directed Treatment with Ivermectin (CDTI) for Onchocerciasis on Parasitological Indicators of Loa loa Infection Hugues C. Nana-Djeunga 1,*, Cédric G. Lenou-Nanga 1, Cyrille Donfo-Azafack 1, Linda Djune-Yemeli 1, Floribert Fossuo-Thotchum 1, André Domche 1, Arsel V. Litchou-Tchuinang 1, Jean Bopda 1, Stève Mbickmen-Tchana 1, Thérèse Nkoa 2, Véronique Penlap 3, Francine Ntoumi 4,5 and Joseph Kamgno 1,6,* 1 Centre for Research on Filariasis and Other Tropical Diseases, P.O. Box 5797, Yaoundé, Cameroon; lenoucedric@gmail.com (C.G.L.-N.); cyrilledo4000@gmail.com (C.D.-A.); djune.linda@gmail.com (L.D.-Y.); floribertf@yahoo.com (F.F.-T.); domche_andre@yahoo.fr (A.D.); larvadel@gmail.com (A.V.L.-T.); bopda@crfilmt.org (J.B.); mbickmen@crfilmt.org (S.M.-T.) 2 Ministry of Public Health, Yaoundé, Cameroon; thereseparasitologie@yahoo.com 3 Department of Biochemistry, Faculty of Science, University of Yaoundé 1, P.O. Box 812, Yaoundé, Cameroon; v.penlap@yahoo.fr 4 Fondation Congolaise pour la Recherche Médicale (FCRM), Brazzaville CG-BZV, Republic of the Congo; fntoumi@fcrm-congo.com 5 Faculty of Science and Technology, Marien Ngouabi University, P.O. Box 69, Brazzaville, Republic of the Congo 6 Department of Public Health, Faculty of Medicine and Biomedical Sciences, University of Yaoundé 1, P.O. Box 1364, Yaoundé, Cameroon * Correspondence: nanadjeunga@crfilmt.org (H.C.N.-D.); kamgno@crfilmt.org (J.K.); Tel.: +237-699-076-499 (H.C.N.-D.); +237-677-789-736 (J.K.) Received: 24 October 2020; Accepted: 9 December 2020; Published: 12 December 2020 Abstract: Ivermectin (IVM) is a broad spectrum endectocide whose initial indication was onchocerciasis.
    [Show full text]
  • Resistant Pseudosuccinea Columella Snails to Fasciola Hepatica (Trematoda) Infection in Cuba : Ecological, Molecular and Phenotypical Aspects Annia Alba Menendez
    Comparative biology of susceptible and naturally- resistant Pseudosuccinea columella snails to Fasciola hepatica (Trematoda) infection in Cuba : ecological, molecular and phenotypical aspects Annia Alba Menendez To cite this version: Annia Alba Menendez. Comparative biology of susceptible and naturally- resistant Pseudosuccinea columella snails to Fasciola hepatica (Trematoda) infection in Cuba : ecological, molecular and phe- notypical aspects. Parasitology. Université de Perpignan; Instituto Pedro Kouri (La Havane, Cuba), 2018. English. NNT : 2018PERP0055. tel-02133876 HAL Id: tel-02133876 https://tel.archives-ouvertes.fr/tel-02133876 Submitted on 20 May 2019 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Délivré par UNIVERSITE DE PERPIGNAN VIA DOMITIA En co-tutelle avec Instituto “Pedro Kourí” de Medicina Tropical Préparée au sein de l’ED305 Energie Environnement Et des unités de recherche : IHPE UMR 5244 / Laboratorio de Malacología Spécialité : Biologie Présentée par Annia ALBA MENENDEZ Comparative biology of susceptible and naturally- resistant Pseudosuccinea columella snails to Fasciola hepatica (Trematoda) infection in Cuba: ecological, molecular and phenotypical aspects Soutenue le 12 décembre 2018 devant le jury composé de Mme. Christine COUSTAU, Rapporteur Directeur de Recherche CNRS, INRA Sophia Antipolis M. Philippe JARNE, Rapporteur Directeur de recherche CNRS, CEFE, Montpellier Mme.
    [Show full text]
  • Efficacy and Safety of High-Dose Ivermectin for Reducing Malaria
    JMIR RESEARCH PROTOCOLS Smit et al Protocol Efficacy and Safety of High-Dose Ivermectin for Reducing Malaria Transmission (IVERMAL): Protocol for a Double-Blind, Randomized, Placebo-Controlled, Dose-Finding Trial in Western Kenya Menno R Smit1, MD, MPH; Eric Ochomo2, PhD; Ghaith Aljayyoussi1, PhD; Titus Kwambai2,3, MSc, MD; Bernard Abong©o2, MSc; Nabie Bayoh4, PhD; John Gimnig4, PhD; Aaron Samuels4, MHS, MD; Meghna Desai4, MPH, PhD; Penelope A Phillips-Howard1, PhD; Simon Kariuki2, PhD; Duolao Wang1, PhD; Steve Ward1, PhD; Feiko O ter Kuile1, MD, PhD 1Liverpool School of Tropical Medicine (LSTM), Liverpool, United Kingdom 2Centre for Global Health Research, Kenya Medical Research Institute (KEMRI), Kisumu, Kenya 3Kisumu County, Kenya Ministry of Health (MoH), Kisumu, Kenya 4Division of Parasitic Diseases and Malaria, Center for Global Health, U.S. Centers for Disease Control and Prevention (CDC), Atlanta, GA, United States Corresponding Author: Menno R Smit, MD, MPH Liverpool School of Tropical Medicine (LSTM) Pembroke Place Liverpool, L3 5QA United Kingdom Phone: 254 703991513 Fax: 44 1517053329 Email: menno.smit@lstmed.ac.uk Abstract Background: Innovative approaches are needed to complement existing tools for malaria elimination. Ivermectin is a broad spectrum antiparasitic endectocide clinically used for onchocerciasis and lymphatic filariasis control at single doses of 150 to 200 mcg/kg. It also shortens the lifespan of mosquitoes that feed on individuals recently treated with ivermectin. However, the effect after a 150 to 200 mcg/kg oral dose is short-lived (6 to 11 days). Modeling suggests higher doses, which prolong the mosquitocidal effects, are needed to make a significant contribution to malaria elimination.
    [Show full text]